New York State declared measles free
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
Biotechnology | Diagnostics | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics
Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
UPenn’s Center for Neurodegenerative Disease Research received an $18.1 million grant from NIH
On Sept. 30, 2019, UPenn’s Center for Neurodegenerative Disease Research (CNDR) received an $18.1 million grant from the…
UPenn created the first ‘bile duct-on-a-chip’
On Sept. 25, 2019, UPenn researchers led by Rebecca Wells, MD, announced they had created the first-ever ‘bile…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteï¾’s Janelia Research Campus announced that they had…
University of Alberta researchers discovered the protein PEX3 in the cells of deadly parasite trypanosome
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
Sylvester Comprehensive Cancer Center announced it had received NCI designation
On Jul. 29, 2019, Sylvester Comprehensive Cancer Center announced it had achieved National Cancer Institute (NCI) designation, becoming…
Chembio Diagnostics and Takeda Pharmaceutical announced collaboration to develop point-of-care diagnostic test
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
Chembio Diagnostics received CE Mark for point-of-care multiplex test for Zika, Dengue and Chikungunya
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 signed into law
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…
Biotechnology | CRISPR | Diagnostics | Genomics | Life Science News | Non-Profit Research | Therapeutics
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Therapeutics
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) announced that it had authorized InBios’ marketing…
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
The University of Alabama’s newest cancer-killing cyclotron was installed
On Mar. 5, 2019, Emma, the 90-ton cyclotron which is the centerpiece of the new proton therapy initiative…
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research
On Jan. 18, 2019 Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
Emory University School of Medicine received a $500,000 grant from CDC to research children’s recovery from mild traumatic brain injury (mTBI)
On Jan. 7, 2019, the Emory University School of Medicine received a $500,000 grant from the Centers for…
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
FNIH Biomarkers Consortium and Critical Path Institute achieve qualification of a clinical safety biomarker
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…